Table 2.
Overview of Solicited Adverse Events and Other Indicators of Reactogenicity in the Overall Population During a 7-day Period Following the First Vaccination and Second Vaccination
| After First Vaccination |
After Second Vaccination |
|||||||
|---|---|---|---|---|---|---|---|---|
| 3.75 µg-Half MF59 (N = 204) | 7.5 µg-Full MF59 (N = 207) | 15 µg-No MF59 (N = 200) | Total (N = 611) | 3.75 µg-Half MF59 (N = 195) | 7.5 µg-Full MF59 (N = 196) | 15 µg-No MF59 (N = 197) | Total (N = 588) | |
| Any reaction, n (%) | 124 (61) | 153 (74) | 103 (52) | 380 (62) | 95 (49) | 98 (50) | 90 (46) | 283 (48) |
| Local reactions, n (%) | 102 (50) | 129 (62) | 78 (39) | 309 (51) | 79 (41) | 88 (45) | 65 (33) | 232 (39) |
| Systemic reactions, n (%) | 80 (39) | 93 (45) | 65 (33) | 238 (39) | 56 (29) | 56 (29) | 51 (26) | 163 (28) |
| Other reactions, n (%) | 15 (7) | 21 (10) | 7 (4) | 43 (7) | 6 (3) | 8 (4) | 9 (5) | 23 (4) |